IQVIA – Global Trends in R&D, 2024

Biomedical advancements are revolutionizing healthcare worldwide, with the COVID-19 pandemic prompting a reset and refocus on opportunities to improve human biology understanding, develop new treatments, and demonstrate clinical value. The report analyzes trends in new drug launches, initiated clinical trials, R&D funding, and company activities. The study also examines the innovation ecosystem's acceleration and adaptability, exploring factors impacting R&D productivity. Conducted independently by the IQVIA Institute for Human Data Science, the research is based on proprietary databases and third-party sources, excluding sponsor trial information. The report credits contributions from numerous IQVIA team members and invites readers to visit iqviainstitute.org to access future reports or join their mailing list.